Compare MIST & EAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MIST | EAD |
|---|---|---|
| Founded | 2003 | 2003 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.3M | 356.3M |
| IPO Year | 2019 | N/A |
| Metric | MIST | EAD |
|---|---|---|
| Price | $0.37 | $5.88 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $3.86 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 342.1K |
| Earning Date | 11-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.91% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $215.89 | N/A |
| Revenue Next Year | $157.01 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.36 | $5.86 |
| 52 Week High | $3.06 | $6.92 |
| Indicator | MIST | EAD |
|---|---|---|
| Relative Strength Index (RSI) | 29.89 | 36.38 |
| Support Level | N/A | N/A |
| Resistance Level | $0.84 | $6.11 |
| Average True Range (ATR) | 0.08 | 0.06 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 2.26 | 14.52 |
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Allspring Income Opportunities Fund is a diversified closed-end management investment company. The Fund seeks a high level of current income. Capital appreciation is a secondary objective. The fund has single operating segment.